Breaking News
Get 50% Off 0
📖 Your Q2 Earnings Guide: Discover the Stocks ProPicks AI Highlights to Jump Post-Earnings Read more
Close

Genfit (GNFTp)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
3.26 0.00    0.00%
03/04 - Closed. Currency in EUR ( Disclaimer )
Type:  Equity
Market:  Euro Zone
ISIN:  FR0004163111 
  • Volume: 0
  • Bid/Ask: 4.14 / 4.22
  • Day's Range: 3.26 - 3.26
Genfit 3.26 0.00 0.00%

EPA:GNFTp Financials

 
A brief overview of the EPA:GNFT financials. This summary provides an overview of the most significant critical numbers from each of its financial reports, including the income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health. Users can select to view data from four periods of either annual or quarterly information, allowing them to track financial performance of Genfit over time.

Genfit S.A. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was EUR 28.57 million compared to EUR 20.2 million a year ago. Revenue was EUR 38.18 million compared to EUR 26.57 million a year ago. Net loss was EUR 28.89 million compared to EUR 23.72 million a year ago. Basic loss per share from continuing operations was EUR 0.58 compared to EUR 0.48 a year ago. Diluted loss per share from continuing operations was EUR 0.58 compared to EUR 0.48 a year ago.

AnnualQuarterly  
Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

GNFTp Income Statement

Gross margin TTM 100%
Operating margin TTM -89.49%
Net Profit margin TTM -83.79%
Return on Investment TTM -17.24%
 Total Revenue  Net Income
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Revenue 9.69 9.69 7.56 7.56
Gross Profit 9.69 9.69 7.56 7.56
Operating Income -5.45 -5.45 -9.98 -9.98
Net Income -4.02 -4.02 -10.43 -10.43

GNFTp Balance Sheet

Quick Ratio MRQ 2.5
Current Ratio MRQ 2.94
LT Debt to Equity MRQ 84.54%
Total Debt to Equity MRQ 103.28%
 Total Assets  Total Liabilities
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Assets 173.87 173.87 193.9 193.9
Total Liabilities 105.92 105.92 119.38 119.38
Total Equity 67.95 67.95 74.52 74.52

GNFTp Cash Flow Statement

Cash Flow/Share TTM -1.12
Revenue/Share TTM 0.69
Operating Cash Flow  -39.45%
 Cash  Net Change in Cash
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities -15.18 -15.18 -12.54 -12.54
Cash From Investing Activities -0.224 -0.224 1.34 1.34
Cash From Financing Activities -1.67 -1.67 -0.882 -0.882
Net Change in Cash -17.02 -17.02 -12.09 -12.09
* In Millions of EUR (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

GNFT Comments

Write your thoughts about Genfit SA
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Moms Naim
Moms Naim Jan 02, 2024 6:56AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
GENFIT : ENFIN COMMERCIALISÉE EN 2024, LA BIOTECH GENFIT
Aynaz Rostami
Aynaz Rostami Feb 11, 2021 9:57AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
what's the reason of fall of Genfit?
ziqing liew
ziqing liew Feb 11, 2021 9:57AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
i also want to know
Aynaz Rostami
Aynaz Rostami Feb 11, 2021 9:57AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
dont worry it Will raise soon
Thao Bui
Thao Bui Jun 26, 2020 4:57AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
it cheap to buy
CAC Invest
CAC Invest Jun 09, 2020 5:39AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Trials for NASH will continue after dataset correction
Thms Koprnk
Koprnk Jun 04, 2020 6:57AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
they failed the drug test and NASH drug was the only viable drug that they were developing , so practically they lost almost all value with that failure...
CAC Invest
CAC Invest Jun 04, 2020 6:57AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
not all value but a drug development. they have so many programs to continue
Danny Danny
Danny Danny May 21, 2020 1:03PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
damn what was wrong w this beast? from 2x all the way down to 5 w low volume?
Rajaie Issaid
Rajaie Issaid May 20, 2020 4:15PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Whats the status , will it still go down ?
Malek Brahmi
Malek Brahmi May 20, 2020 4:15PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Yes
stats con chris
stats con chris May 19, 2020 2:27PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
this baby Is the brother of contravirpharma (HEPA) .. same diseases.
MfB Iod
MfB Iod May 19, 2020 2:27PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
what do you mean?
Nedal Aysheh
Nedal Aysheh May 12, 2020 5:53PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
WHAT IS THE BEST STOCK TO BUY TODAY ??/ ANT RECOMMENDATION
MfB Iod
MfB Iod Mar 27, 2019 12:56PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
does anyone have an explaination for the sudden fall same day of the Nasdaq trading?
Show previous replies (5)
Mathieu Gandrille
Mathieu Gandrille Mar 27, 2019 12:56PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
MfB Iod  possible. today it will open low, in a range between 5 to 8. (my guess only - dyor)
Mathieu Gandrille
Mathieu Gandrille Mar 27, 2019 12:56PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
MfB Iod   i changed my recommendation to SELL, with objective at 8.0
MfB Iod
MfB Iod Mar 27, 2019 12:56PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Mathieu Gandrille  ah you mean to buy because it would be oversold
Mathieu Gandrille
Mathieu Gandrille Mar 27, 2019 12:56PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
MfB Iod   i mean if 5 i would buy, and sell at 8
Olivier Bclr
Olivier Bclr Mar 27, 2019 12:56PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Mathieu Gandrille  are you a KOL?
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email